Table 1.
Baseline characteristics
| Patient group | Male (%) | Age (years) | Disease duration (years) | Weakness arm (%) | Weakness leg (%) | CB arm nerves (%) | CB leg nerves (%) |
|---|---|---|---|---|---|---|---|
| MMN (n = 50) | 82 | 51 (33–74) | 10 (2–39) | 100 | 68 | 68 | 24 |
| CIDP (n = 48) | 58 | 54 (22–82) | 4 (0–32) | 88 | 96 | 44 | 19 |
| PSMA (n = 35) | 86 | 61 (35–83) | 12 (4–30) | 86 | 51 | 0 | 0 |
| CIAP (n = 25) | 80 | 75 (61–89) | 13 (4–21) | 28 | 100 | 0 | 0 |
Age and disease duration are given as median (range)
CB conduction block; MMN multifocal motor neuropathy; CIDP chronic inflammatory demyelinating polyneuropathy; PSMA progressive spinal muscular atrophy; CIAP chronic idiopathic axonal polyneuropathy